Laboratorios Liconsa S.A., STADA Arzneimittel AG
PolandAll drugs from this manufacturer
-
Bevimlar is used in adults to reduce the risk of a subsequent heart attack or death from cardiovascular disease (following acute coronary syndrome). It is also used to reduce the risk of blood clots in people with coronary artery disease or peripheral artery disease.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 2.5 mg ATC: B01AF01
-
The medicine is used in adults to prevent the formation of blood clots in the veins following hip or knee replacement surgery. It is also used to treat deep vein thrombosis and pulmonary embolism and to prevent their recurrence.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 10 mg ATC: B01AF01
-
The medicine is used in adults to prevent strokes and other blood clots (in atrial fibrillation), as well as in the treatment and prevention of deep vein thrombosis and pulmonary embolism. In children and adolescents (over 30 kg), it is used for the treatment and prevention of clots in the veins or pulmonary vessels.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 15 mg ATC: B01AF01
-
The medicine is used in adults to prevent strokes and other blood clots (in atrial fibrillation), as well as to treat and prevent blood clots in the leg veins and pulmonary vessels. In children and adolescents (weighing more than 30 kg), it is used to treat and prevent clots in the veins or lungs.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 20 mg ATC: B01AF01
-
The medicine is used in adults to treat blood clots in the veins of the legs (deep vein thrombosis) and in the blood vessels of the lungs (pulmonary embolism), as well as to prevent the recurrence of such clots.
Dosage form: tablets, film-coated
Active substance Dosage rivaroxaban 15 mg or 20 mg ATC: B01AF01
-
The medicine is used in adult patients with type 2 diabetes to regulate blood sugar levels. It helps increase the amount of insulin released after a meal and reduces the amount of sugar produced by the body.
Dosage form: tablets, film-coated
Active substance Dosage sitagliptin 56.688 mg metformin hydrochloride 850 mg ATC: A10BD07
-
The medicine is used in adult patients with type 2 diabetes to balance blood sugar levels. It helps increase the amount of insulin released after a meal and reduces the amount of sugar produced by the body.
Dosage form: tablets, film-coated
Active substance Dosage sitagliptin 50 mg metformin hydrochloride 1000 mg ATC: A10BD07